News Room

Follow:
6822 Articles
Marketing 3 Min Read

Growth in marketing spend, DE&I investments slow: report

Get marketing news you'll actually want to readMarketing Brew informs marketing pros of the latest on brand strategy, social media,

Startups 7 Min Read

The Tech Behind Today’s Wine

Alexander Westgarth is the founder and CEO of WineCap, an investment platform that makes wine investment affordable, transparent and simple.

Leadership 6 Min Read

Successfully Integrating AI To Address Burnout And Enhance Efficiency

Jorge Lukowski, Global Director of Marketing and Communications at NEORIS. The myriad uses of artificial intelligence (AI) in day-to-day operations

Startups 8 Min Read

Competition And Antitrust In The Digital Age

Vinod Jain is an expert in global and digital business, former business professor, consultant, speaker and author of Global Meets

Leadership 9 Min Read

Immigrant Nobel Prize Winners Continue To Impress

In 2023, four of the six U.S. recipients of Nobel Prizes in medicine, chemistry and physics came to America as

Startups 8 Min Read

How To Use Intelligent Automation For Revenue Generation

I’ve recently taken an interest in learning about Intelligent Automation (IA) and its efficiency possibilities in small business. This advanced

Leadership 5 Min Read

Get The Capital You Need To Keep Your Business Moving

These past few years have pushed many businesses to the brink of collapse, due to various reasons. With shaky economic

Startups 7 Min Read

Companies Want Employees Back In The Office—Do Employees Want To Return?

CEO of DeskTime—a time tracking and productivity app for companies and freelancers. He’s also an amateur athlete and father of

Leadership 9 Min Read

How small companies Out-Innovate Big Players

Mid-sized companies have neither the Research and Development budget of big corporations, nor the spirited freedom of a startup. Yet

Startups 6 Min Read

Biomaterials Firm Bolt Threads, Formerly A Unicorn, Plans SPAC Deal At A $250 Million Valuation

CEO Dan Widmaier talks exclusively with Forbes about going public and the ups and downs of running a synthetic biology